½ÃÀ庸°í¼­
»óǰÄÚµå
1405885

Áú ȸÃá ½ÃÀå ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Ä¡·á À¯Çüº°, À¯Çüº°, ¿ëµµº°, ¿¬·É ±¸ºÐº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Vaginal Rejuvenation Market Size, Share & Trend Analysis By Treatment Type (Reconstructive, Cosmetic), By Type, By Application, By Age Category, By Region And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 173 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áú ȸÃá ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ Áú ȸÃá ½ÃÀå ±Ô¸ð´Â 2024-2030³â 22.07%ÀÇ CAGRÀ» ±â·ÏÇϸç, 2030³â±îÁö 143¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Áú ȸÃá ¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁö´Â °ÍÀº Á¦°øµÇ´Â Ä¡·á¹ýÀÇ ¼ö Áõ°¡, ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¶»ç ¿¬±¸ Áõ°¡ ¹× °ü·Ã ³í¶õ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

¶ÇÇÑ ·¹ÀÌÀú ¹× °íÁÖÆÄ ±â¼úÀÇ µµ¿òÀ» ¹Þ¾Æ Ä¡·áÇÏ´Â ºñħ½ÀÀû ½Ã¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀÔ´Ï´Ù. ºÐ¼ö ź»ê°¡½º(CO2) ·¹ÀÌÀúÀÇ Ãâ½Ã´Â À¯¸ÁÇÑ °á°ú¿Í ÇÔ²² ÀλóÀûÀÎ Àα⸦ ¾ò°í ÀÖÀ¸¸ç, CO2 ·¹ÀÌÀú´Â ¿ÜÀ½ºÎ Áú À§ÃàÁõ(VVA) ȯÀÚÀÇ »îÀ» Å©°Ô °³¼±Çß½À´Ï´Ù. ÀÌ´Â ºñħ½ÀÀû Ư¼ºÀ¸·Î ÀÎÇØ ´Ù¿îŸÀÓÀÌ Àû°Å³ª ÀüÇô ¾ø´Â ºñħ½ÀÀû Ư¼º°ú ´õ ³ªÀº °á°ú¿¡ ±âÀÎÇÕ´Ï´Ù.

±×·¯³ª ºÎÀΰú Ä¡·á¿¡ ´ëÇÑ »çȸÀû ³«Àΰú ¿¡³ÊÁö ±â¹Ý ºÎÀΰú Ä¡·á¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦°¡ ½ÃÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº °ü·Ã Ä¡·á¿ë ¿¡³ÊÁö ±â¹Ý ±â±â¸¦ ½ÂÀÎÇÏÁö ¾Ê¾Ò½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â Æó°æ±â, ¿ä½Ç±Ý, ¼º°ü°è µîÀÇ Áõ»ó¿¡ ´ëÇÑ ¾ÈÀü¼º°ú À¯È¿¼ºÀÌ ¾ÆÁ÷ ÀÔÁõµÇÁö ¾Ê¾Ò½À´Ï´Ù.

COVID-19ÀÇ ¹ßº´Àº Àü ¼¼°è ¹Ì¿ë ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ°í, ¿Ü°úÀû ¹Ì¿ë Ä¡·á´Â Å« ÈÄÅ𸦠¸ñ°ÝÇß½À´Ï´Ù. Áú ȸÃá°ú °°Àº ºñº»ÁúÀûÀÎ ¹Ì¿ë ½Ã¼úÀÇ ´ëºÎºÐÀº 2020³â1 ºÐ±â¿Í 2 ºÐ±â »çÀÌ¿¡ ¿ÏÀüÈ÷ ÁߴܵǾúÁö¸¸ ¸¹Àº ÇǺΰú ¹× ¼ö¼ú¼¾ÅÍ´Â 2020³â¸»±îÁö ¼­ºñ½º¸¦ Àç°³ÇÏ´Â µ¥ Áö¼ÓÀûÀÎ ¿ëÀ̼ºÀ» º¸¿© ¿¹Ãø ±â°£ Áß ½ÃÀåÀ» ȸº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Áú ȸÃá ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Ä¡·á À¯Çüº°·Î´Â ƯÈ÷ ¼±Áø±¹¿¡¼­ Áú °ü·Ã ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹Ì¿ë Áú ȸÃá ºÐ¾ß°¡ 2023³â 66.0%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • À¯Çüº°·Î ½ÃÀåÀº ¿Ü°ú¼ö¼ú°ú ºñ¿Ü°ú¼ö¼ú·Î ³ª´¹´Ï´Ù. ¿Ü°ú¼ö¼ú ºÎ¹®Àº 2023³â ½ÃÀåÀÇ 54.0%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • °í·É Ãâ»ê ºÎ¹®Àº 2023³â 43.9%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • 30-40´ë ¿¬·ÉÃþÀÌ 2023³â 42.3%ÀÇ ÁÖ¿ä Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ºÏ¹Ì´Â 2023³â Áú½Ä ¼ö¼ú Áõ°¡¿Í ¼ÒºñÀÚÀÇ ³ôÀº °¡Ã³ºÐ ¼ÒµæÀ¸·Î ÀÎÇØ Å« Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2023³â 28.9%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇßÁö¸¸, ȯÀÚµé »çÀÌ¿¡¼­ ´Ù¾çÇÑ Áú ¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ÇâÈÄ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Áú ȸÃá ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ¾÷°èÀÇ °úÁ¦
  • Áú ȸÃá : ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå Áú ȸÃá ½ÃÀå : Ä¡·á À¯Çüº° ºÎ¹® ºÐ¼®, 2018-2030³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • Ä¡·á À¯ÇüÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áú ȸÃá ½ÃÀå, Ä¡·á À¯Çüº°, 2018-2030³â
  • ÀÌÇÏ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
    • Àç°Ç¼º Áú ȸÃá
    • ¹Ì¿ë Áú ȸÃá

Á¦5Àå Áú ȸÃá ½ÃÀå : À¯Çüº° ºÎ¹® ºÐ¼®, 2018-2030³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • À¯Çü ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áú ȸÃá ½ÃÀå, À¯Çüº°, 2018-2030³â
  • ÀÌÇÏ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
    • ¿Ü°úÀû
    • ºñ¿Ü°úÀû

Á¦6Àå Áú ȸÃá ½ÃÀå : ¿ëµµº° ºÎ¹® ºÐ¼®, 2018-2030³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áú ȸÃá ½ÃÀå, ¿ëµµº°, 2018-2030³â
  • ÀÌÇÏ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
    • ¿ä½Ç±Ý
    • °í·ÉÈ­¿Í Ãâ»ê
    • ¹ÌÀû ¸ñÀû
    • ±âŸ

Á¦7Àå Áú ȸÃá ½ÃÀå : ¿¬·É ±¸ºÐº° ºÎ¹® ºÐ¼®, 2018-2030³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • ¿¬·É ±¸ºÐÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áú ȸÃá ½ÃÀå, ¿¬·É ±¸ºÐº°, 2018-2030³â
  • ÀÌÇÏ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
    • 20¼¼ ¹Ì¸¸/20-30¼¼
    • 30-40¼¼
    • 40¼¼ ÀÌ»ó

Á¦8Àå Áú ȸÃá ½ÃÀå : Áö¿ª ½ÃÀå ºÐ¼®, 2018-2030³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ª ½ÃÀå ½º³À¼ô
  • 2018-2030³â ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м® :
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ű¹
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå Áú ȸÃá ½ÃÀå - °æÀï ºÐ¼®

  • Key companies profiled
    • Alma Lasers
    • Lutronic
    • Hironic
    • Viveve
    • BTL Group of Companies
    • VenusConcept
    • Fotona
    • Candela Corporation
KSA 24.01.23

Vaginal Rejuvenation Market Growth & Trends:

The global vaginal rejuvenation market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 22.07% from 2024 to 2030, according to a new report by Grand View Research, Inc. The Growing popularity of vaginal rejuvenation surgery due to the rising number of treatments offered, increasing demand for the surgery, a growing number of research studies, and associated controversies are propelling the market.

In addition, the growing adoption of non-invasive procedures, such as treatment with the help of laser and radiofrequency technologies is market. The launch of fractional carbon dioxide (CO2) laser has gained impressive popularity with promising results. It has significantly improved the lives of vulvovaginal atrophy (VVA) patients. This can be attributed to its non-invasive nature with less or no downtime and better results.

However, the social stigma associated with gynecological treatments and stringent regulations for energy-based gynecological treatments is hampering the market. The food and Drug Administration (FDA) has not approved any energy-based devices for the associated therapy. These devices have not yet established safety and effectiveness in conditions, such as menopause, incontinence, or intercourse.

The onset of COVID-19 affected the global aesthetic market with surgical cosmetic treatments witnessing a significant setback. The majority of the non-essential cosmetic procedures like vaginal rejuvenation were completely halted during the first and second quarters of 2020, however many dermatology and surgical centers have witnessed perpetual ease in reopening their services by the end of 2020 might help recover the market during the forecast period.

Vaginal Rejuvenation Market Report Highlights:

  • By treatment type, The cosmetic vaginal rejuvenation segment held the largest market share of 66.0% in 2023 due to the growing demand for vaginal-associated surgeries, especially in the developed countries
  • By type, the market is divided into surgical and non-surgical. The surgical segment held the largest market share of 54.0% in 2023 of the market.
  • The aging and childbirth segment held the largest market share of 43.9% in 2023 of the market.
  • The 30-40 segment accounted for the major share of 42.3% in 2023 of the market.
  • North America registered a significant share in 2023 owing to the increasing number of vaginal procedures performed and the high disposable income of consumers
  • The Asia Pacific market dominated the market with a revenue share of 28.9% in 2023 is expected to grow considerably in the future owing to the growing popularity of various vaginal surgeries among patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment type
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. Age Category
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key type scope to conclude on the market size

Chapter 2. Executive Summary

Chapter 3. Vaginal Rejuvenation Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
    • 3.1.2. Market Restraint Analysis
    • 3.1.3. Industry Challenges
  • 3.2. Vaginal Rejuvenation: Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier Power
      • 3.2.1.2. Buyer Power
      • 3.2.1.3. Substitution Threat
      • 3.2.1.4. Threat from new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political Landscape
      • 3.2.2.2. Environmental Landscape
      • 3.2.2.3. Social Landscape
      • 3.2.2.4. Technology Landscape
      • 3.2.2.5. Legal Landscape

Chapter 4. Vaginal Rejuvenation Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Treatment Type market share analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Vaginal Rejuvenation Market, by Treatment Type, 2018 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Reconstructive Vaginal Rejuvenation
      • 4.5.1.1. Perineoplasty
      • 4.5.1.2. Vaginoplasty
    • 4.5.2. Cosmetic Vaginal Rejuvenation
      • 4.5.2.1. G-Spot amplification
      • 4.5.2.2. Labioplasty
      • 4.5.2.3. Hymenoplasty
      • 4.5.2.4. Hoodectomy

Chapter 5. Vaginal Rejuvenation Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Type market share analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Vaginal Rejuvenation Market, by Type, 2018 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgical
    • 5.5.2. Non-surgical

Chapter 6. Vaginal Rejuvenation Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Application market share analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Vaginal Rejuvenation Market, by Application, 2018 to 2030
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Incontinence
    • 6.5.2. Aging and Childbirth
    • 6.5.3. Aesthetic Purposes
    • 6.5.4. Others

Chapter 7. Vaginal Rejuvenation Market: Segment Analysis, by Age Category, 2018 - 2030 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. Age Category market share analysis, 2023 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Vaginal Rejuvenation Market, by Age Category, 2018 to 2030
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Below 20/20-30
    • 7.5.2. 30-40
    • 7.5.3. 40 and above

Chapter 8. Vaginal Rejuvenation Market: Regional Market Analysis, 2018 - 2030 (USD Million)

  • 8.1. Definitions & Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 8.6. North America
    • 8.6.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 8.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. U.S.
      • 8.6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4. Canada
      • 8.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Europe
    • 8.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 8.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. U.K.
      • 8.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. Germany
      • 8.7.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. France
      • 8.7.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.6. Italy
      • 8.7.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.7. Spain
      • 8.7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.8. Denmark
      • 8.7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.9. Sweden
      • 8.7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.10. Norway
      • 8.7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 8.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Japan
      • 8.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4. China
      • 8.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.5. India
      • 8.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.6. Korea
      • 8.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.7. Thailand
      • 8.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.8. Australia
      • 8.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 8.9.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.3. Brazil
      • 8.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.4. Mexico
      • 8.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.5. Argentina
      • 8.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.10. Middle East and Africa
    • 8.10.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 8.10.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.3. South Africa
      • 8.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.4. Saudi Arabia
      • 8.10.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.5. UAE
      • 8.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.6. Kuwait
      • 8.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Vaginal Rejuvenation Market - Competitive Analysis

  • 9.1. Key companies profiled
    • 9.1.1. Alma Lasers
      • 9.1.1.1. Company Overview
      • 9.1.1.2. Financial Performance
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. Lutronic
      • 9.1.2.1. Company Overview
      • 9.1.2.2. Financial Performance
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Hironic
      • 9.1.3.1. Company Overview
      • 9.1.3.2. Financial Performance
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Viveve
      • 9.1.4.1. Company Overview
      • 9.1.4.2. Financial Performance
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. BTL Group of Companies
      • 9.1.5.1. Company Overview
      • 9.1.5.2. Financial Performance
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. VenusConcept
      • 9.1.6.1. Company Overview
      • 9.1.6.2. Financial Performance
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. Fotona
      • 9.1.7.1. Company Overview
      • 9.1.7.2. Financial Performance
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Candela Corporation
      • 9.1.8.1. Company Overview
      • 9.1.8.2. Financial Performance
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦